Interleukin-13/-4-induced oxidative stress contributes to death of hippocampal neurons in Aβ 1-42-treated hippocampus in vivo

Antioxidants and Redox Signaling

Volumn 16, Issue 12, 2012, Pages 1369-1383

  Nam, J H ^a,b   Park, K W ^a,b   Park, E S ^a,b   Lee, Y B ^c   Lee, H G ^c   Baik, H H ^a,b   Kim, Y S ^d   Maeng, S ^a   Park, J ^a   Jin, B K ^a,b  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; INTERLEUKIN 4; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; FEMALE; HIPPOCAMPAL CA1 REGION; HYPOTHESIS; IN VIVO STUDY; MICROGLIA; MOUSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; BLOTTING, WESTERN; CELL DEATH; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-13; INTERLEUKIN-4; MICE; NEURONS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS;

EID: 84860120752     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4175     Document Type: Article

References (55)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, Mcgeer PL, O'banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421, 2000. (Pubitemid 30349107)
2. Akiyama H, Ikeda K, Kondo H, and Mcgeer PL. Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett 146: 152-154, 1992.
3. Bergamini S, Rota C, Canali R, Staffieri M, Daneri F, Bini A, Giovannini F, Tomasi A, and Iannone A. N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide 5: 349-360, 2001. (Pubitemid 32735387)
4. Block ML. NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 9: S8, 2008.
5. Brusselle GG, Kips JC, Tavernier JH, Van Der Heyden JG, Cuvelier CA, Pauwels RA, and Bluethmann H. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 24: 73-80, 1994. (Pubitemid 24210819)
6. Butovsky O, Talpalar AE, Ben-Yaakov K, and Schwartz M. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci 29: 381-393, 2005. (Pubitemid 40799211)
7. Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, and Rizzarelli E. Cellular stress response: A novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33: 2444-2471, 2008.
8. Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, and Rott O. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 153: 4258-4267, 1994. (Pubitemid 24322593)
9. Chao CC, Molitor TW, and Hu S. Neuroprotective role of IL-4 against activated microglia. J Immunol 151: 1473-1481, 1993. (Pubitemid 23219285)
10. Choi BH, Kim RC, Vaughan PJ, Lau A, Van Nostrand WE, Cotman CW, and Cunningham DD. Decreases in protease nexins in Alzheimer's disease brain. Neurobiol Aging 16: 557-562, 1995.
11. Choi SH, Lee DY, Kim SU, and Jin BK. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: Role of microglial NADPH oxidase. J Neurosci 25: 4082-4090, 2005.
12. Chong YH, Jung JM, Choi W, Park CW, Choi KS, and Suh YH. Bacterial expression, purification of full length and carboxyl terminal fragment of Alzheimer amyloid precursor protein and their proteolytic processing by thrombin. Life Sci 54: 1259-1268, 1994. (Pubitemid 24107408)
13. Chung YC, Kim SR, and Jin BK. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease. J Immunol 185: 1230-1237, 2010.
14. Corren J. Cytokine inhibition in severe asthma: Current knowledge and future directions. Curr Opin Pulm Med 17: 29-33, 2011.
15. Cross AR and Segal AW. The NADPH oxidase of professional phagocytes-Prototype of the NOX electron transport chain systems. Biochim Biophys Acta 1657: 1-22, 2004. (Pubitemid 38823040)
16. Furlan R, Poliani PL, Marconi PC, Bergami A, Ruffini F, Adorini L, Glorioso JC, Comi G, and Martino G. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Ther 8: 13-19, 2001. (Pubitemid 32162411)
17. Gordon MN, Holcomb LA, Jantzen PT, Dicarlo G, Wilcock D, Boyett KW, Connor K, Melachrino J, O'callaghan JP, and Morgan D. Time course of the development of Alzheimerlike pathology in the doubly transgenic PS1 + APP mouse. Exp Neurol 173: 183-195, 2002. (Pubitemid 34151370)
18. Harper RW, Xu C, Eiserich JP, Chen Y, Kao CY, Thai P, Setiadi H, and Wu R. Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 579: 4911-4917, 2005. (Pubitemid 41218684)
19. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, and Floyd RA. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18: 8126-8132, 1998. (Pubitemid 28464991)
20. Igarashi K, Murai H, and Asaka J. Proteolytic processing of amyloid beta protein precursor (APP) by thrombin. Biochem Biophys Res Commun 185: 1000-1004, 1992.
21. Jankowsky JL, Slunt HH, Gonzales V, Jenkins NA, Copeland NG, and Borchelt DR. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging 25: 885-892, 2004. (Pubitemid 38813168)
22. Janus C and Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol Behav 73: 873-886, 2001. (Pubitemid 32885575)
23. Lee SI, Jeong SR, Kang YM, Han DH, Jin BK, Namgung U, and Kim BG. Endogenous expression of interleukin-4 regulates macrophage activation and confines cavity formation after traumatic spinal cord injury. J Neurosci Res 88: 2409-2419, 2010.
24. Liu SH, Yang CN, Pan HC, Sung YJ, Liao KK, Chen WB, Lin WZ, and Sheu ML. IL-13 downregulates PPAR-gamma/heme oxygenase-1 via ER stress-stimulated calpain activation: aggravation of activated microglia death. Cell Mol Life Sci 67: 1465-1476, 2010.
25. Lovell MA and Markesbery WR. Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol 58: 392-396, 2001. (Pubitemid 32217455)
26. Lyons A, Griffin RJ, Costelloe CE, Clarke RM, and Lynch MA. IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro. J Neurochem 101: 771-781, 2007. (Pubitemid 46633315)
27. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Evanoff HL, Strieter RM, and Kunkel SL. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J Immunol 164: 2738-2744, 2000. (Pubitemid 30115507)
28. Medeiros R, Prediger RD, Passos GF, Pandolfo P, Duarte FS, Franco JL, Dafre AL, Di Giunta G, Figueiredo CP, Takahashi RN, Campos MM, and Calixto JB. Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: Relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J Neurosci 27: 5394-5404, 2007. (Pubitemid 46790177)
29. Millucci L, Ghezzi L, Bernardini G, and Santucci A. Conformations and biological activities of amyloid beta peptide 25-35. Curr Protein Pept Sci 11: 54-6-7, 2010.
30. Moon JH, Kim SY, Lee HG, Kim SU, and Lee YB. Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia. Exp Mol Med 40: 11-18, 2008. (Pubitemid 351346812)
31. Numata I, Okuyama R, Memezawa A, Ito Y, Takeda K, Furuyama K, Shibahara S, and Aiba S. Functional expression of heme oxygenase-1 in human differentiated epidermis and its regulation by cytokines. J Invest Dermatol 129: 2594-2603, 2009.
32. Paludan SR, Lovmand J, Ellermann-Eriksen S, and Mogensen SC. Effect of IL-4 and IL-13 on IFN-gamma-induced production of nitric oxide inmouse macrophages infectedwith herpes simplex virus type 2. FEBS Lett 414: 61-64, 1997. (Pubitemid 27380355)
33. Park KW, Baik HH, and Jin BK. Interleukin-4-induced oxidative stress via microglial NADPH oxidase contributes to the death of hippocampal neurons in vivo. Curr Aging Sci 1: 192-201, 2008.
34. Park KW, Baik HH, and Jin BK. IL-13-induced oxidative stress via microglial NADPH oxidase contributes to death of hippocampal neurons in vivo. J Immunol 183: 4666-4674, 2009.
35. Park KW and Jin BK. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: Role of neuronal NADPH oxidase. J Neurosci Res 86: 1053-1063, 2008. (Pubitemid 351441303)
36. Park KW, Lee DY, Joe EH, Kim SU, and Jin BK. Neuroprotective role of microglia expressing interleukin-4. J Neurosci Res. 81: 397-402, 2005. (Pubitemid 41359294)
37. Paxinos G and Watson C. The Rat Brain in Sterotaxic Coordinates. San Diego: Academic. 1998.
38. Ryu JK, Franciosi S, Sattayaprasert P, Kim SU, and Mclarnon JG. Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia 48: 85-90, 2004. (Pubitemid 39390851)
39. Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, and Fujimoto S. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun 273: 5-9, 2000. (Pubitemid 30426853)
40. Shin WH, Lee DY, Park KW, Kim SU, Yang MS, Joe EH, and Jin BK. Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia 46: 142-152, 2004. (Pubitemid 38596180)
41. Sinha S, Kaler LJ, Proctor TM, Teuscher C, Vandenbark AA, and Offner H. IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis. J Immunol 180: 2679-2685, 2008.
42. Szaingurten-Solodkin I, Hadad N, and Levy R. Regulatory role of cytosolic phospholipase A2alpha in NADPH oxidase activity and in inducible nitric oxide synthase induction by aggregated Abeta1-42 in microglia. Glia 57: 1727-1740, 2009.
43. Szczepanik AM, Funes S, Petko W, and Ringheim GE. IL-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 113: 49-62, 2001. (Pubitemid 32008670)
44. Thinakaran G and Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283: 29615-29619, 2008.
45. Tomlinson KL, Davies GC, Sutton DJ, and Palframan RT. Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite. PLoS One 5: e13136, 2010.
46. Vaughan PJ, Su J, Cotman CW, and Cunningham DD. Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease. Brain Res 668: 160-170, 1994.
47. Walch L, Massade L, Dufilho M, Brunet A, and Rendu F. Pro-atherogenic effect of interleukin-4 in endothelial cells: Modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression. Atherosclerosis 187: 285-291, 2006. (Pubitemid 43963018)
48. Weiner HL and Frenkel D. Immunology and immunotherapy of Alzheimer's disease. Nat Rev Immunol 6: 404-416, 2006.
49. Wenzel S, Wilbraham D, Fuller R, Getz EB, and Longphre M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: Results of two phase 2a studies. Lancet 370: 1422-1431, 2007. (Pubitemid 47576168)
50. Wilkinson BL and Landreth GE. The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J Neuroinflamm 3: 30, 2006.
51. Williamson KS, Gabbita SP, Mou S, West M, Pye QN, Markesbery WR, Cooney RV, Grammas P, Reimann-Philipp U, Floyd RA, and Hensley K. The nitration product 5-nitrogamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 6: 221-227, 2002. (Pubitemid 34848445)
52. Won SY, Choi SH, and Jin BK. Prothrombin kringle-2-induced oxidative stress contributes to the death of cortical neurons in vivo and in vitro: role of microglial NADPH oxidase. J Neuroimmunol 214: 83-92, 2009.
53. Yang G, Li L, Volk A, Emmell E, Petley T, Giles-Komar J, Rafferty P, Lakshminarayanan M, Griswold DE, Bugelski PJ, and Das AM. Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice. J Pharmacol Exp Ther 313: 8-15, 2005. (Pubitemid 40411322)
54. Yang G, Volk A, Petley T, Emmell E, Giles-Komar J, Shang X, Li J, Das AM, Shealy D, Griswold DE, and Li L. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 28: 224-232, 2004. (Pubitemid 39573497)
55. Yu JT, Lee CH, Yoo KY, Choi JH, Li H, Park OK, Yan B, Hwang IK, Kwon YG, Kim YM, and Won MH. Maintenance of anti-inflammatory cytokines and reduction of glial activation in the ischemic hippocampal CA1 region preconditioned with lipopolysaccharide. J Neurol Sci 296: 69-78, 2010.